Ulf is a co‑founder and CEO of T‑CURX, with more than 20 years of experience in founding, building, and successfully exiting biotechnology companies. Prior to T‑CURX, he co‑founded 4‑Antibody AG and NBE‑Therapeutics, both of which were acquired by international pharma companies, and led the companies as CEO through significant venture financings and major commercial transactions. Ulf holds a PhD in Biochemistry and has an extensive background in immunology, with over 40 peer‑reviewed publications and multiple granted and pending patents.